ter scale at which the ellipse of growth inhibition intercepted the test strip. Any intercept value which fell between two points on the scale was rounded up to the next higher value. All isolates, including control organisms, were tested in triplicate for susceptibility to moxifloxacin (Bayer Pharmaceuticals, West Haven, Conn.), ceftriaxone (Roche, Nutley, N.J.), ciprofloxacin (Miles Laboratories, West Haven, Conn.), clindamycin (Upjohn Co., Kalamazoo, Mich.), and metronidazole (McGaw, Irvine, Calif.).
The P. acnes strains in this study were the same strains as those in our previous study (7) . All strains demonstrated highlevel susceptibilities to moxifloxacin, ceftriaxone, ciprofloxacin, and clindamycin by the E test. The MICs of moxifloxacin were within 1 antibiotic dilution of each other (0.094 to 0.125 g/ ml). MICs clustered around 0.25 g/ml for ciprofloxacin, with a range of 0.38 to 0.19 g/ml. There was greater variability in P. acnes susceptibility to ceftriaxone, with MICs ranging from 0.064 to 0.38 g/ml. For 50% of the organisms tested, the MIC was 0.38 g/ml. For the majority of the isolates, the MIC of clindamycin was either 0.032 or 0.047 g/ml. For two isolates, the MICs were somewhat higher: 0.125 and 0.25 g/ml. All isolates were found to be resistant to metronidazole. Results are shown in Table 1 .
P. acnes clinical isolates demonstrated high-level in vitro susceptibilities to moxifloxacin, ciprofloxacin, ceftriaxone, and clindamycin and resistance to metronidazole. Results obtained for moxifloxacin, ceftriaxone, ciprofloxacin, clindamycin, and metronidazole are in agreement with previously reported findings (1-3, 7) .
Interestingly, the MICs of ciprofloxacin were lower for several P. acnes clinical isolates compared with data from our previous study. The MICs of ciprofloxacin were comparable to those of sparfloxacin and ofloxacin in that study. We did not test ofloxacin or sparfloxacin in the present study.
On the basis of our study, all the clinical eye isolates were susceptible to the new fluoroquinolone. This study supplements existing information regarding the in vitro susceptibility of P. acnes. The data presented suggest that moxifloxacin is a suitable antimicrobial agent for evaluation in a rabbit model of P. acnes endophthalmitis. Ͼ256  Ͼ256  Ͼ256  Ͼ256  Ͼ256  Ͼ256  Ͼ256  Ͼ256  Ͼ256  Ͼ256  Ͼ256  Ͼ256  Ͼ256  1 
